DK1161449T3 - Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer - Google Patents
Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrerInfo
- Publication number
- DK1161449T3 DK1161449T3 DK00916028T DK00916028T DK1161449T3 DK 1161449 T3 DK1161449 T3 DK 1161449T3 DK 00916028 T DK00916028 T DK 00916028T DK 00916028 T DK00916028 T DK 00916028T DK 1161449 T3 DK1161449 T3 DK 1161449T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- amyloid peptide
- group
- compounds
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12273699P | 1999-03-04 | 1999-03-04 | |
PCT/US2000/005574 WO2000052048A1 (en) | 1999-03-04 | 2000-03-03 | Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1161449T3 true DK1161449T3 (da) | 2007-11-05 |
Family
ID=22404455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00916028T DK1161449T3 (da) | 1999-03-04 | 2000-03-03 | Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer |
Country Status (19)
Country | Link |
---|---|
US (3) | US6610658B1 (da) |
EP (1) | EP1161449B1 (da) |
JP (2) | JP2002543043A (da) |
KR (1) | KR100771712B1 (da) |
CN (1) | CN1279053C (da) |
AT (1) | ATE366259T1 (da) |
AU (1) | AU781292B2 (da) |
BR (1) | BR0008738A (da) |
CA (1) | CA2362834C (da) |
CY (1) | CY1106899T1 (da) |
DE (1) | DE60035412T2 (da) |
DK (1) | DK1161449T3 (da) |
ES (1) | ES2290023T3 (da) |
HK (1) | HK1040722B (da) |
NZ (1) | NZ514414A (da) |
PT (1) | PT1161449E (da) |
RU (1) | RU2260599C2 (da) |
WO (1) | WO2000052048A1 (da) |
ZA (1) | ZA200107913B (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
WO1997021728A1 (en) | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
CN1279053C (zh) * | 1999-03-04 | 2006-10-11 | 普雷西斯药品公司 | 含有D-氨基酸的β-淀粉样肽聚集的调节因子 |
US7060670B1 (en) | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
GB9917725D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
US20020094335A1 (en) * | 1999-11-29 | 2002-07-18 | Robert Chalifour | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
US20070135337A2 (en) * | 1999-11-29 | 2007-06-14 | Neurochem (International) Limited | Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
WO2001058470A2 (en) * | 2000-02-11 | 2001-08-16 | Praecis Pharmaceuticals Incorporated | Methods for enhancing the bioavailability of a drug |
AUPR215700A0 (en) * | 2000-12-19 | 2001-01-25 | Fujisawa Pharmaceutical Co., Ltd. | Carboxylic acid compound having cyclopropane ring |
DE10117281A1 (de) * | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
AU2003226607C1 (en) | 2002-04-18 | 2011-02-24 | Yeda Research And Development Co. Ltd. | Derivatives of NIK, their production and use |
BR0317747A (pt) * | 2002-12-24 | 2005-11-22 | Neurochem Int Ltd | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave |
CN100340599C (zh) * | 2003-06-09 | 2007-10-03 | 湖南大学 | 多聚赖氨酸淀粉纳米颗粒与制备方法及作为基因载体的应用 |
GB0503434D0 (en) * | 2005-02-18 | 2005-03-30 | Senexis Ltd | Amyloid-binding peptides, analogues and uses thereof |
DOP2006000278A (es) * | 2005-12-12 | 2007-07-15 | Hoffmann La Roche | Glicosilación en la región variable |
JP2010518064A (ja) | 2007-02-12 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | Adおよび関連状態の治療のためのピペラジン誘導体 |
DE102008037564A1 (de) * | 2008-11-19 | 2010-05-20 | Forschungszentrum Jülich GmbH | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
EP2510357B1 (en) * | 2009-12-07 | 2016-03-30 | Pieris AG | Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target |
JP2014529630A (ja) | 2011-09-07 | 2014-11-13 | ザウラー−ブロシュ、ローラント | 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤 |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
KR101437354B1 (ko) * | 2012-07-27 | 2014-09-05 | 한국과학기술연구원 | 고수율 및 고순도의 아밀로이드-베타 펩타이드의 제조방법 |
KR20230128606A (ko) * | 2022-02-28 | 2023-09-05 | 경상국립대학교산학협력단 | 티로신을 유효성분으로 함유하는 알츠하이머병의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR82516E (fr) * | 1962-10-11 | 1964-02-28 | Ciba Geigy | Procédé de préparation de dérivés peptidiques, notamment d'hydrazides peptidiques |
US4119493A (en) | 1975-10-23 | 1978-10-10 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US5284664A (en) | 1988-08-04 | 1994-02-08 | Kremers-Urban Company | Method of treating the symptoms of Alzheimer's disease |
US5652214A (en) | 1989-06-05 | 1997-07-29 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
US5338663A (en) | 1990-08-24 | 1994-08-16 | President And Fellows Of Harvard College | Method of identifying inhibitors of β-protein esterase activity |
US5434050A (en) | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
US6120768A (en) | 1993-05-17 | 2000-09-19 | Immunomedics, Inc. | Dota-biotin derivatives |
WO1994028412A1 (en) | 1993-05-28 | 1994-12-08 | The Miriam Hospital | Composition and method for in vivo imaging of amyloid deposits |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
CA2125467C (en) | 1993-07-06 | 2001-02-06 | Heinz Dobeli | Process for producing hydrophobic polypeptides, proteins or peptides |
AU7556994A (en) | 1993-08-13 | 1995-03-14 | Molecular Geriatrics Corporation | Methods for the diagnosis of alzheimer's disease |
GB9317120D0 (en) | 1993-08-17 | 1993-09-29 | Royal Postgrad Med School | Human serum amyloid p component |
US5652334A (en) | 1993-09-08 | 1997-07-29 | City Of Hope | Method for design of substances that enhance memory and improve the quality of life |
US5470951A (en) | 1993-09-29 | 1995-11-28 | City Of Hope | Peptides for antagonizing the effects of amyloid βprotein |
US5744368A (en) | 1993-11-04 | 1998-04-28 | Research Foundation Of State University Of New York | Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR) |
JPH07149668A (ja) | 1993-11-30 | 1995-06-13 | Kanegafuchi Chem Ind Co Ltd | アミロイド沈着検出用物質 |
US5935927A (en) | 1994-02-03 | 1999-08-10 | The Picower Institute For Medical Research | Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts |
US6303567B1 (en) * | 1995-03-14 | 2001-10-16 | Praecis Pharmaceuticals, Inc . | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
ATE218583T1 (de) * | 1995-03-14 | 2002-06-15 | Praecis Pharm Inc | Verbindungen mit aggregations-modulierenden wirkung auf das amyloid protein |
US5767233A (en) | 1995-05-12 | 1998-06-16 | Schering Corporation | Soluble cleavable substrates of the hepatitis C virus protease |
US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US5985242A (en) | 1995-10-27 | 1999-11-16 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
WO1997021728A1 (en) * | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
EP1586584A1 (en) * | 1996-08-27 | 2005-10-19 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
CN1279053C (zh) * | 1999-03-04 | 2006-10-11 | 普雷西斯药品公司 | 含有D-氨基酸的β-淀粉样肽聚集的调节因子 |
-
2000
- 2000-03-03 CN CNB008071926A patent/CN1279053C/zh not_active Expired - Fee Related
- 2000-03-03 AT AT00916028T patent/ATE366259T1/de not_active IP Right Cessation
- 2000-03-03 CA CA002362834A patent/CA2362834C/en not_active Expired - Fee Related
- 2000-03-03 DE DE60035412T patent/DE60035412T2/de not_active Expired - Lifetime
- 2000-03-03 WO PCT/US2000/005574 patent/WO2000052048A1/en active IP Right Grant
- 2000-03-03 JP JP2000602272A patent/JP2002543043A/ja active Pending
- 2000-03-03 EP EP00916028A patent/EP1161449B1/en not_active Expired - Lifetime
- 2000-03-03 DK DK00916028T patent/DK1161449T3/da active
- 2000-03-03 KR KR1020017011038A patent/KR100771712B1/ko not_active IP Right Cessation
- 2000-03-03 RU RU2001127246/04A patent/RU2260599C2/ru active
- 2000-03-03 NZ NZ514414A patent/NZ514414A/xx unknown
- 2000-03-03 PT PT00916028T patent/PT1161449E/pt unknown
- 2000-03-03 AU AU37196/00A patent/AU781292B2/en not_active Ceased
- 2000-03-03 US US09/519,019 patent/US6610658B1/en not_active Expired - Fee Related
- 2000-03-03 BR BR0008738-6A patent/BR0008738A/pt not_active Application Discontinuation
- 2000-03-03 ES ES00916028T patent/ES2290023T3/es not_active Expired - Lifetime
-
2001
- 2001-09-26 ZA ZA200107913A patent/ZA200107913B/xx unknown
-
2002
- 2002-03-25 HK HK02102235.9A patent/HK1040722B/zh not_active IP Right Cessation
-
2003
- 2003-03-24 US US10/395,290 patent/US6831066B2/en not_active Expired - Fee Related
-
2004
- 2004-11-15 US US10/989,763 patent/US7803774B2/en not_active Expired - Fee Related
-
2007
- 2007-10-02 CY CY20071101254T patent/CY1106899T1/el unknown
-
2010
- 2010-12-24 JP JP2010287097A patent/JP2011121952A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000052048A9 (en) | 2002-04-11 |
JP2002543043A (ja) | 2002-12-17 |
EP1161449B1 (en) | 2007-07-04 |
CN1362967A (zh) | 2002-08-07 |
AU781292B2 (en) | 2005-05-12 |
ATE366259T1 (de) | 2007-07-15 |
KR100771712B1 (ko) | 2007-10-30 |
KR20020007316A (ko) | 2002-01-26 |
HK1040722A1 (en) | 2002-06-21 |
US20030236197A1 (en) | 2003-12-25 |
US7803774B2 (en) | 2010-09-28 |
CN1279053C (zh) | 2006-10-11 |
US20050137128A1 (en) | 2005-06-23 |
HK1040722B (zh) | 2008-02-22 |
DE60035412D1 (de) | 2007-08-16 |
CY1106899T1 (el) | 2012-09-26 |
ES2290023T3 (es) | 2008-02-16 |
US6610658B1 (en) | 2003-08-26 |
CA2362834C (en) | 2005-12-06 |
CA2362834A1 (en) | 2000-09-08 |
PT1161449E (pt) | 2007-10-12 |
WO2000052048A1 (en) | 2000-09-08 |
NZ514414A (en) | 2004-02-27 |
RU2260599C2 (ru) | 2005-09-20 |
BR0008738A (pt) | 2001-12-26 |
EP1161449A1 (en) | 2001-12-12 |
AU3719600A (en) | 2000-09-21 |
JP2011121952A (ja) | 2011-06-23 |
US6831066B2 (en) | 2004-12-14 |
DE60035412T2 (de) | 2008-02-14 |
ZA200107913B (en) | 2002-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106899T1 (el) | Διαμορφωτες συσσωματωσης βητα-αμυλοειδων πεπτιδιων που περιλαμβανουν d-αμινοξεα | |
DK0929574T3 (da) | Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer | |
AR023208A1 (es) | Nutraceuticos con 1-metil ester de n-[n-3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina | |
DE69713112T2 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
DE69635493D1 (de) | Verfahren zur herstellung von l-aminosäuren | |
ATE406383T1 (de) | Verkürzte tau proteine | |
DE60041119D1 (de) | Verfahren zur präsentation von (poly)peptiden/proteinen auf bakteriophagenpartikeln via disulfidbindungen | |
ATE244015T1 (de) | Formulierungen fuer faktor ix | |
BR9707819A (pt) | Imunogenos peptidicos | |
DE60023860D1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
WO2005060683A3 (en) | Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders | |
ATE331037T1 (de) | Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff | |
ATE290315T1 (de) | Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits | |
PT896615E (pt) | Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio | |
DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid | |
DK1077717T3 (da) | Anvendelse af lipopeptider eller lipoproteiner til sårbehandling | |
EP1080724A4 (en) | COMPOSITIONS FOR REDUCING MTP ACTIVITY | |
DK0946590T3 (da) | Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid | |
DE69413637D1 (de) | Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia | |
EP1870419A3 (en) | Modulators of beta-amyloid peptide aggregation comprising d-amino acids | |
ATE346091T1 (de) | Neues diagnostisches reagens und kit zur erkennung von rickettsiose | |
DE59915086D1 (de) | Rekombinante l-n-carbamoylase aus arthrobacter aurescens, verfahren zur herstellung von l-aminosäuren mittels dieser | |
MX9206339A (es) | Nueva proteina inhibidora de trombina a partir de chinches de monte | |
FI973551A0 (fi) | Vaetska foer fukt/sprejavkylningsanlaeggningar | |
BR9714382A (pt) | 17alfa-diidroequilina para uso como um antioxidante médico |